Literature DB >> 14600376

Arylnaphthalide lignans from Cleistanthus collinus.

Chimmani Ramesh1, Nasi Ravindranath, Tejomoortula Siva Ram, Biswanath Das.   

Abstract

Chemical examination of the aerial parts of Cleistanthus collinus afforded the arylanphthalide lignans, cleistanone (1), diphyllin (2), cleistanthins A (3), C (4) and D (5), and 4-O-(3"-O-methyl-beta-D-glucopyranosyl)-diphyllin (6). The first compound is a new member of the rare group of arylnaphthalide lignans containing an alkoxy group on the lactone ring. The structure of the compound was determined from its spectral data, chemical transformations and partial synthesis from diphyllin (2). The new lignan, 1 and its acetyl derivative, 7 were found to exhibit cytotoxicity against MT(2) cell lines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14600376     DOI: 10.1248/cpb.51.1299

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  10 in total

Review 1.  Arylnaphthalene lactone analogues: synthesis and development as excellent biological candidates for future drug discovery.

Authors:  Chuang Zhao; K P Rakesh; Saira Mumtaz; Balakrishna Moku; Abdullah M Asiri; Hadi M Marwani; H M Manukumar; Hua-Li Qin
Journal:  RSC Adv       Date:  2018-03-06       Impact factor: 4.036

2.  Cleistanthus collinus poisoning.

Authors:  Anugrah Chrispal
Journal:  J Emerg Trauma Shock       Date:  2012-04

3.  Antiproliferative Compounds from Cleistanthus boivinianus from the Madagascar Dry Forest.

Authors:  Yixi Liu; Kelly Young; L Harinantenaina Rakotondraibe; Peggy J Brodie; Jessica D Wiley; Maria B Cassera; Martin W Callmander; R Rakotondrajaona; Etienne Rakotobe; Vincent E Rasamison; Karen TenDyke; Yongchun Shen; David G I Kingston
Journal:  J Nat Prod       Date:  2015-06-19       Impact factor: 4.050

4.  Evaluation and structure-activity relationship analysis of a new series of arylnaphthalene lignans as potential anti-tumor agents.

Authors:  Jiaoyang Luo; Yichen Hu; Weijun Kong; Meihua Yang
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

5.  Evaluation of the antihypertensive activity and alpha adrenergic receptor interaction of cleistanthins A and B.

Authors:  R P Priyadharsini; S Parasuraman; R Raveendran
Journal:  J Basic Clin Pharm       Date:  2014-09

6.  A novel potent autophagy inhibitor ECDD-S27 targets vacuolar ATPase and inhibits cancer cell survival.

Authors:  Jiraporn Paha; Phongthon Kanjanasirirat; Bamroong Munyoo; Patoomratana Tuchinda; Naravut Suvannang; Chanin Nantasenamat; Kanokthip Boonyarattanakalin; Prasat Kittakoop; Sirawit Srikor; Gunganist Kongklad; Noppawan Rangkasenee; Suradej Hongeng; Pongsak Utaisincharoen; Suparerk Borwornpinyo; Marisa Ponpuak
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

7.  Cleistanthus collinus Poisoning.

Authors:  Alladi Mohan; Janjam Harikrishna
Journal:  Indian J Crit Care Med       Date:  2019-12

8.  Diphyllin Shows a Broad-Spectrum Antiviral Activity against Multiple Medically Important Enveloped RNA and DNA Viruses.

Authors:  Michal Štefánik; Dattatry Shivajirao Bhosale; Jan Haviernik; Petra Straková; Martina Fojtíková; Lucie Dufková; Ivana Huvarová; Jiří Salát; Jan Bartáček; Jan Svoboda; Miloš Sedlák; Daniel Růžek; Andrew D Miller; Luděk Eyer
Journal:  Viruses       Date:  2022-02-09       Impact factor: 5.048

9.  Rapid Preparative Isolation of Cleistanthin A from the Leaves of Cleistanthus Collinus Using Reverse-Phase Flash Chromatography.

Authors:  S C Santosh Kumar; R Raveendran; Kamsali Murali Mohan Achari
Journal:  J Pharm Bioallied Sci       Date:  2022-07-18

10.  Potent cytotoxic arylnaphthalene lignan lactones from Phyllanthus poilanei.

Authors:  Yulin Ren; Daniel D Lantvit; Youcai Deng; Ragu Kanagasabai; Judith C Gallucci; Tran Ngoc Ninh; Hee-Byung Chai; Djaja D Soejarto; James R Fuchs; Jack C Yalowich; Jianhua Yu; Steven M Swanson; A Douglas Kinghorn
Journal:  J Nat Prod       Date:  2014-06-12       Impact factor: 4.050

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.